<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/A0A585E0-6B0D-4643-A3A6-47943B4CBFEF"><gtr:id>A0A585E0-6B0D-4643-A3A6-47943B4CBFEF</gtr:id><gtr:name>University of Liverpool</gtr:name><gtr:department>Sch of Biological Sciences</gtr:department><gtr:address><gtr:line1>Senate House</gtr:line1><gtr:line2>Abercromby Square</gtr:line2><gtr:line4>Liverpool</gtr:line4><gtr:postCode>L69 3BX</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/A0A585E0-6B0D-4643-A3A6-47943B4CBFEF"><gtr:id>A0A585E0-6B0D-4643-A3A6-47943B4CBFEF</gtr:id><gtr:name>University of Liverpool</gtr:name><gtr:address><gtr:line1>Senate House</gtr:line1><gtr:line2>Abercromby Square</gtr:line2><gtr:line4>Liverpool</gtr:line4><gtr:postCode>L69 3BX</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>PROJECT_PARTNER</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/8D381AAA-E001-4B4F-8C29-3C468F3AFC6C"><gtr:id>8D381AAA-E001-4B4F-8C29-3C468F3AFC6C</gtr:id><gtr:firstName>Jerry</gtr:firstName><gtr:surname>Turnbull</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/C33FE08B-D543-444C-B273-679DAA53C2E5"><gtr:id>C33FE08B-D543-444C-B273-679DAA53C2E5</gtr:id><gtr:firstName>Scott</gtr:firstName><gtr:surname>Guimond</gtr:surname><gtr:roles><gtr:role><gtr:name>RESEARCHER_COI</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=BB%2FF006616%2F1"><gtr:id>A28FB915-47BA-413F-A8B7-8C089DE831B1</gtr:id><gtr:title>Extracellular Modulation of Multiprotein Signalling Complexes: Molecular Regulation of FGFR Signalling by Anosmin &amp;amp; Heparan Sulphate Proteoglycans</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>BB/F006616/1</gtr:grantReference><gtr:abstractText>Defects of a recently discovered protein called anosmin-1, or of a signaling protein called fibroblast growth factor receptor 1 (FGFR1), cause Kallmann's syndrome, an inherited human disorder resulting from abnormal development of neurons involved in smell and hormone-releasing functions. We recently discovered that anosmin-1 functions through interactions with FGFR1 signalling complexes that involve binding to a complex polysaccharide called heparan sulphate (HS), resulting in amplified responses. Our data provide the first evidence for anosmin-1 acting as a specific modulator of FGFR1 signalling and reveal a defined molecular mechanism linking the 2 genetic forms of Kallmans syndrome. In this project we are planning to characterize in more detail the molecular mechanisms of HS-dependent regulation of FGFR signalling by anosmin-1. We will use a variety of molecular, cell and structural biology techniques to examine the functional interactions between these molecules. These studies will provide insights into the regulation of multiprotein complexes involved in receptor signalling processes. The results will extend our understanding of the molecular mechanisms for the normal function of anosmin-1 and HS in FGFR signalling during human nervous system development, as well as in abnormal development in Kallmann's syndrome. This work could help to identify new targets for treating this syndrome, and also underpin the development of novel applications in tissue engineering and nerve regeneration.</gtr:abstractText><gtr:technicalSummary>Defects of either anosmin-1 or fibroblast growth factor receptor 1 (FGFR1) underlie hereditary Kallmann's syndrome (KS), a human disorder of olfactory and gonadotropin-releasing hormone-1 (GnRH-1) neuronal ontogeny. We recently discovered a functional interaction between anosmin-1 and the multiprotein FGFR1/FGF2/heparan sulphate (HS) complex where anosmin-1 acts as an isoform-specific co-ligand enhancing FGFR1 signalling activity. Here we propose to further characterise the nature of anosmin-1 interaction with the FGF/HS/FGFR1 complex in order to develop an understanding of the molecular mechanisms of anosmin-1 action on FGFR1 signalling. We will: (1) map the binding sites of anosmin-1 with its interacting partners and determine the HS specificity necessary for these interactions (2) determine the FGFR/FGF subtype specificities in anosmin-1-mediated signalling (3) evaluate the functional and structural impacts of loss-of-function mutations in anosmin-1 and FGFR1 which confer KS phenotype (4) identify the HSPG core protein involved in anosmin-1/FGFR1 signalling and examine the possible cooperative signalling pathways (5) develop studies on the structural basis of anosmin-1 function in FGFR1 activation by CD spectroscopy and crystallographic structure determination of anosmin-1 and its complexes These studies will extend our understanding of the molecular mechanisms of normal function of anosmin-1 and HS in FGFR signalling during both normal and abnormal human nervous system development. Overall, this will provide novel insights of fundamental significance on multiprotein complexes involved in regulation of cell surface receptor signalling processes.</gtr:technicalSummary><gtr:fund><gtr:end>2010-12-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/2512EF1C-401B-4222-9869-A770D4C5FAC7"><gtr:id>2512EF1C-401B-4222-9869-A770D4C5FAC7</gtr:id><gtr:name>BBSRC</gtr:name></gtr:funder><gtr:start>2008-01-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>319884</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Media releases on research findings</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>09F875C1-73C6-482F-9AF4-ABEEE75C1158</gtr:id><gtr:impact>University press releases on the novel Alzheimer drug hits we discovered, along with developments in synthetic chemistry of our sugars, and applications in nerve repair and cancer therapeutics

International press coverage, radio interviews (Radio City Liverpool), and TV news (BBC NW Tonight).</gtr:impact><gtr:outcomeId>664F9A23EAF</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2006,2007,2008,2012,2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Outreach to Business Community</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>99FEEF7B-86EB-4CA0-80D3-297B5AE20C25</gtr:id><gtr:impact>Article in magazine Research Intelligence by UoL Business Gateway,(see website link &amp;quot;Sweet Smell of Success&amp;quot; http://www.liv.ac.uk/researchintelligence/issue30/alzheimers.html)

Dissemination of information to business community</gtr:impact><gtr:outcomeId>5ABD8E4DF77</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:url>http://www.liv.ac.uk/researchintelligence/issue30/alzheimers.html</gtr:url><gtr:year>2007</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>RCUK/BBSRC event: Lifelong Health: Bioscience of Ageing (at Westminster)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>D2AE6B45-742F-4FB9-8A9B-A4491E9B1817</gtr:id><gtr:impact>Poster highlighting discovery of new class of drugs for AD at the RCUK/BBSRC event: 2007 Lifelong Health: Bioscience of Ageing (at Westminster)

Dissemination of information on research success to MPs and policymakers</gtr:impact><gtr:outcomeId>4FDB8F2C434</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Policymakers/parliamentarians</gtr:primaryAudience><gtr:year>2007</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Supporting ARUK fund raising publicity with major London donor</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>9B08CBD7-01F8-4AAB-87D0-15C2C8751422</gtr:id><gtr:impact>Supporters engaged directly with researcher undertaking research activity.

As above</gtr:impact><gtr:outcomeId>53889defdeaad5.02672164</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Supporters</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Hosting visit to Liverpool University by local ARUK funding supporters</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>4DD7CCDC-473B-433C-B868-EEB0C19BD476</gtr:id><gtr:impact>Contact was invaluable in informing supporters directly about research activities supported in Liverpool by their fund raising efforts

Funding supporters were able to gain insights into new potential treatments for AD, and how their funding is used for research.</gtr:impact><gtr:outcomeId>53889ecec48c68.47147256</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Supporters</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Public Lecture to Garston Rotary Club</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>E62BF5DF-AA50-402F-879A-49F708E27D48</gtr:id><gtr:impact>Lecture to Garston Rotary Club

Contributing the Public Understanding of Science</gtr:impact><gtr:outcomeId>E03C6115FF2</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2008</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Public lecture to Liverpool Soroptimists Club</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>7A989CC9-2168-442A-96BF-7CAD44F144B3</gtr:id><gtr:impact>Talk sparked many questions and discussion of AD and potential new drugs and diagnostics

Contribution to Public Understanding of Science</gtr:impact><gtr:outcomeId>5464a2a09d1b27.42175603</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:keyFindingsOutput><gtr:description>New understading of signalling pathway regulation by extracelluar complexes of proteins with proteoglycans</gtr:description><gtr:exploitationPathways>Further research</gtr:exploitationPathways><gtr:id>84FC4D4F-4D7C-4287-AB62-6EEB67A18213</gtr:id><gtr:outcomeId>5464c2509ecb02.30829715</gtr:outcomeId><gtr:sectors><gtr:sector>Healthcare,Pharmaceuticals and Medical Biotechnology</gtr:sector></gtr:sectors></gtr:keyFindingsOutput><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>F2E20A7E-0D2E-417E-BEFA-8FD64828FD90</gtr:id><gtr:title>Extracellular matrix and cell signalling: the dynamic cooperation of integrin, proteoglycan and growth factor receptor.</gtr:title><gtr:parentPublicationTitle>The Journal of endocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/624bbc02186f52ed82f477482cc2f056"><gtr:id>624bbc02186f52ed82f477482cc2f056</gtr:id><gtr:otherNames>Kim SH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0022-0795</gtr:issn><gtr:outcomeId>5464cbb296fd72.92848468</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3DF46AA7-A104-48DA-9730-98939707B9E0</gtr:id><gtr:title>Novel mechanisms of fibroblast growth factor receptor 1 regulation by extracellular matrix protein anosmin-1.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/138f33a3f01c841c7c7260f7700fecd5"><gtr:id>138f33a3f01c841c7c7260f7700fecd5</gtr:id><gtr:otherNames>Hu Y</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>5464caa6118976.61447272</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E46E75C1-3F43-4959-AD50-7C11806DA346</gtr:id><gtr:title>Distinct patterns of heparan sulphate in pancreatic islets suggest novel roles in paracrine islet regulation.</gtr:title><gtr:parentPublicationTitle>Molecular and cellular endocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/06b857b733f594992ba6c8a4087b72d8"><gtr:id>06b857b733f594992ba6c8a4087b72d8</gtr:id><gtr:otherNames>Theodoraki A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0303-7207</gtr:issn><gtr:outcomeId>546498c5e5fbe4.45643901</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">BB/F006616/1</gtr:identifier></gtr:identifiers><gtr:healthCategories/><gtr:researchActivities/><gtr:researchSubjects/><gtr:researchTopics><gtr:researchTopic><gtr:id>D05BC2E0-0345-4A3F-8C3F-775BC42A0819</gtr:id><gtr:text>Unclassified</gtr:text></gtr:researchTopic></gtr:researchTopics><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>